Clinical Trial Update: A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE) [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of cenerimod in adult Chinese participants with moderate-to-severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Cenerimod (cenerimod)

Snippet

Sponsor: Viatris Pharmaceuticals Co., Ltd. | Conditions: SLE - Systemic Lupus Erythematosus | Phase 2 | Status: ENROLLING_BY_INVITATION